Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Brain Derived Neurotropic Factor Level and val66met Polymorphism of Brain Derived Neurotropic Factor Gene in Patients With Type Two Diabetes Mellitus and Depression

NCT05526131 is registered in ClinicalTrials.gov with Kasr El Aini Hospital as lead sponsor.

NCT NCT05526131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05526131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Brain Derived Neurotropic Factor Level and val66met Polymorphism of Brain Derived Neurotropic Factor Gene in Patients With Type Two Diabetes Mellitus and Depression
Lead sponsor
Kasr El Aini Hospital
Phase
Not applicable
Overall status
Completed
Start date
February 17, 2021
Completion date
October 23, 2021
Enrollment
88 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, diabetes mellitus